Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Foamix Pharmaceuticals Ltd.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Foamix Pharmaceuticals Ltd. since year 2005.
Table 2 shows the detailed insider transactions of Foamix Pharmaceuticals Ltd. since 2005.
The reporting company's ticker symbol is FOMX. The reporting company's CIK number is 1606645.
The total value of stock buying since 2005 is $0.
The total value of stock sales since 2005 is $257,167.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2018-03-02||Elliott Russell P. (VP Drug Development)||Sale||817||6.14||5,016|
|2018-03-01||Domzalski David (CEO)||Sale||66||5.95||392|
|2018-01-15||Shirvan Mitchell (VP Innovation & Discovery)||Option Ex||562||.00||0|
|2018-01-15||Schuz David (VP IP)||Option Ex||562||.00||0|
|2018-01-15||Hazot Yohan (VP Pharmaceutical Development)||Option Ex||562||.00||0|
|2018-01-15||Hadar Ilan (CFO & Country Manager)||Option Ex||562||.00||0|
|2018-01-15||Eini Meir||Option Ex||1,125||.00||0|
|2018-01-01||Elliott Russell P. (VP Drug Development)||Option Ex||1,372||.00||0|
|2018-01-01||Domzalski David (CEO)||Option Ex||5,948||.00||0|
|2018-01-01||Shirvan Mitchell (VP Innovation & Discovery)||Option Ex||2,745||.00||0|
|2018-01-01||Schuz David (VP IP)||Option Ex||2,745||.00||0|
|2018-01-01||Hazot Yohan (VP Pharmaceutical Development)||Option Ex||4,575||.00||0|
|2018-01-01||Hadar Ilan (CFO & Country Manager)||Option Ex||5,032||.00||0|
|2018-01-01||Eini Meir||Option Ex||5,032||.00||0|
|2018-01-01||Howard Alvin D (VP Regulatory)||Option Ex||2,288||.00||0|
Insider trading activities including stock purchases, stock sales, and option exercises of FOMX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Foamix Pharmaceuticals Ltd. (symbol FOMX, CIK number 1606645) see the Securities and Exchange Commission (SEC) website.